These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6761000)

  • 21. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

  • 22. The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.
    Günzler WA; Steffens GJ; Otting F; Kim SM; Frankus E; Flohé L
    Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1155-65. PubMed ID: 6754569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assay method for urinary urokinase using synthetic fluorogenic substrate (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Rinsho Byori; 1979 Mar; 27(3):218-22. PubMed ID: 439470
    [No Abstract]   [Full Text] [Related]  

  • 24. The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.
    Shariat SF; Casella R; Monoski MA; Sulser T; Gasser TC; Lerner SP
    J Urol; 2003 Dec; 170(6 Pt 1):2244-7. PubMed ID: 14634389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complete amino acid sequence of low molecular mass urokinase from human urine.
    Steffens GJ; Günzler WA; Otting F; Frankus E; Flohé L
    Hoppe Seylers Z Physiol Chem; 1982 Sep; 363(9):1043-58. PubMed ID: 6754572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of plasminogen activators in human kidney and male genital organs using a highly sensitive enzyme immunoassay.
    Hasui Y; Suzumiya J; Sumiyoshi A; Hashida S; Ishikawa E
    Thromb Res; 1988 Aug; 51(4):453-9. PubMed ID: 3142095
    [No Abstract]   [Full Text] [Related]  

  • 27. Resistance of bovine band 3, a hydrophobic erythrocyte membrane protein, to denaturation of guanidine hydrochloride.
    Makino S; Nakashima H; Shibagaki K
    J Biochem; 1981 Feb; 89(2):651-8. PubMed ID: 7240133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary urokinase and blood fibrinolytic activity in patients with nephrolithiasis and other urinary tract diseases].
    Kotschy M; Lorenz T; Kaniak J; Janukowicz-Lorenz H; Lorenz J; Dabrowska B
    Pol Tyg Lek; 1975 Oct; 30(43):1773-7. PubMed ID: 52868
    [No Abstract]   [Full Text] [Related]  

  • 29. Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.
    Hekman CM; Loskutoff DJ
    Biochemistry; 1988 Apr; 27(8):2911-8. PubMed ID: 2969749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence and characterization of stable intermediate state(s) in the unfolding of ovomucoid by guanidine hydrochloride.
    Baig MA; Salahuddin A
    Biochem J; 1978 Apr; 171(1):89-97. PubMed ID: 646827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
    Seetharam R; Dwivedi AM; Duke JL; Hayman AC; Walton HL; Huckins NR; Kamerkar SM; Corman JI; Woodeshick RW; Wilk RR
    Biochemistry; 1992 Oct; 31(41):9877-82. PubMed ID: 1382596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)].
    Wakayama Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutant forms of staphylococcal nuclease with altered patterns of guanidine hydrochloride and urea denaturation.
    Shortle D; Meeker AK
    Proteins; 1986 Sep; 1(1):81-9. PubMed ID: 3449854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
    Sumi H; Kosugi T; Matsuo O; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):119-28. PubMed ID: 7051725
    [No Abstract]   [Full Text] [Related]  

  • 35. [Urina urokinase and blood fibrinolytic activity in w experimental zinc poisoning].
    Guja A
    Patol Pol; 1977; 28(2):201-8. PubMed ID: 887291
    [No Abstract]   [Full Text] [Related]  

  • 36. Secondary structure in ribonuclease. I. Equilibrium folding transitions seen by amide circular dichroism.
    Labhardt AM
    J Mol Biol; 1982 May; 157(2):331-55. PubMed ID: 6286979
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.
    Astedt B; Holmberg L
    Nature; 1976 Jun; 261(5561):595-7. PubMed ID: 819839
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversible denaturation of thermophilic malate dehydrogenase by guanidine hydrochloride and acid.
    Iijima S; Saiki T; Beppu T
    J Biochem; 1984 May; 95(5):1273-81. PubMed ID: 6746606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of urokinase and anticoagulant activity of the urine in patients suffering from hemorrhagic fever with renal syndrome].
    Abdurashitov RF
    Urol Nefrol (Mosk); 1977; (3):10-2. PubMed ID: 17936
    [No Abstract]   [Full Text] [Related]  

  • 40. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
    Hettle JA; Balekjian E; Tung PS; Fritz IB
    Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.